People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their ...

TUESDAY, Dec. 10, 2024 (HealthDay News) -- People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be ...

Glucagon-like peptide 1 receptor agonists and fenofibrates may protect patients with type 2 diabetes against diabetic macular ...

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

The agency is due to make a determination on the shortage status of Zepbound by Dec. 19. But another delay could be possible ...

New findings presented at ASH indicated that GLP-1 agonists led to a significant reduction in the risk for dangerous blood ...

Propensity-score matched analysis showed that VTE rates at 1 year were 20% lower for patients starting on a GLP-1 drug rather ...

Now, research from Henry Ford Health, has found that weight-loss drugs, including GLP-1, could also impact alcohol ...

People with diabetes who took medications like Ozempic or Wegovy had a lower risk of serious blood clots compared to people ...

GLP-1 drugs are quickly becoming some of the most ubiquitous in the U.S., and they have drawn interest for their potential ...

A new study found that adults over the age of 60 and on a GLP-1 medication reduced their likelihood of developing dementia by ...

Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.